Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of ...

In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) ("Dundee" or the "Corporation") announces that its wholly owned subsidiary, Dundee ...